BioElectronics Corp is primarily active in the medical device industry.

The main competitors of BioElectronics Corp in the market include TENSPros, Omron Healthcare, and Zynex Medical.

BioElectronics Corp is a leading medical device company specializing in the development and manufacturing of innovative, drug-free, and non-invasive wearable medical devices. The company was founded in 2000 and is headquartered in Frederick, Maryland. BioElectronics Corp is committed to improving the quality of life for individuals suffering from acute and chronic pain through advanced technology and medical expertise. With a strong focus on research and development, the company has garnered recognition globally for their groundbreaking products, including ActiPatch® and RecoveryRx™. BioElectronics Corp continues to revolutionize the field of pain management with its cutting-edge solutions.

BioElectronics Corp has achieved several significant milestones in its journey. The company successfully developed innovative medical devices, such as ActiPatch and RecoveryRx, which utilize pulsed electromagnetic field technology. These devices have gained regulatory approvals in multiple countries, allowing BioElectronics Corp to expand its global reach. Furthermore, the company has formed partnerships with renowned healthcare distributors, enhancing its distribution network and market presence. BioElectronics Corp has also conducted numerous clinical studies validating the efficacy of its products in pain reduction and recovery. These achievements highlight the company's commitment to revolutionizing pain management and improving patients' quality of life.

BioElectronics Corp is primarily present in the United States.

BioElectronics Corp represents values of innovation, sustainability, and patient-centered care. With a corporate philosophy focused on improving people's lives, the company develops and markets innovative medical devices that utilize bioelectronic technology. BioElectronics Corp aims to provide safe, effective, and drug-free options for pain management and recovery. Their commitment to research and development allows them to stay at the forefront of medical advancements and deliver high-quality products to patients worldwide. By harnessing the power of bioelectronic technology, BioElectronics Corp strives to revolutionize the way pain and inflammation are treated, ultimately enhancing people's well-being and quality of life.

Converted at the current exchange rate, the BioElectronics share trades at 0,00 EUR (0,00 USD).

The BioElectronics Corp is an American Medtech company that specializes in the development and marketing of innovative medical devices. The company's core business focuses on the production and sale of medical electronics, particularly wearable devices. This technology aims to alleviate pain and accelerate healing without relying on strong medications. In the field of medical electronics, BioElectronics currently offers various products including the ActiPatch, the Allay Menstrual Pain Therapy System, and the RecoveryRx Circulation Booster. These devices all employ electromagnetic therapy to promote the body's natural healing process. For example, the ActiPatch is a compact, portable device used in pain therapy. It can be applied to various body parts and functions through continuous low-frequency electrostimulation. On the other hand, the Allay Menstrual Pain Therapy System is a specialized device used for treating cramps during menstruation. It is worn on the lower abdomen and functions through electrical stimulation. Another important aspect of BioElectronics' business is research and development. The company collaborates closely with leading experts in the field of electromedicine to develop innovative solutions for various medical problems. The company invests significant resources in research and development to ensure that its products are at the forefront of technology and best suited to meet customer needs. BioElectronics also pursues a business model of partnering with various companies and organizations in the field of electromedicine. For example, the company has formed a partnership with the University of Oxford to investigate the effects of electromagnetic therapy on patients with chronic pain. It also collaborates with the National Aeronautics and Space Administration (NASA) to explore how this type of therapy can support the physical recovery of astronauts during extended missions. The company has also expanded into international markets and formed partnerships with various companies and organizations in Europe and Asia. The aim is to establish a greater global presence and promote access to its products. In summary, BioElectronics Corp's business model is focused on improving pain therapy and healing through innovative medical devices. The company emphasizes the development of medical electronics, particularly wearable devices, to provide non-invasive therapy without relying on strong medications. With a strong emphasis on research and development, collaboration with other companies and organizations, and international expansion, BioElectronics is well positioned to play a leading role in the field of electromedicine.

Käivet ei saa praegu BioElectronics kohta arvutada.

Kasumit ei saa praegu BioElectronics kohta arvutada.

P/E-suhtarvu ei saa praegu BioElectronics kohta arvutada.

P/S-suhtarvu ei saa praegu BioElectronics kohta arvutada.

Eulpooli kvaliteedinäitaja BioElectronics jaoks on 4/10.

BioElectronics ISIN on US09062H1086. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

BioElectronics WKN on A0J2WS. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.

BioElectronics ticker on BIEL. Ticker-sümbol kasutatakse BioElectronics aktsiate kauplemiseks börsil.

BioElectronics maksis dividende igal aastal viimase 0 aasta jooksul.

BioElectronics kuulub sektorisse '—'.

BioElectronics dividendid jagatakse välja valuutas USD.